| # | Drug | Count |
|---|---|---|
| 0 | ALEMTUZUMAB | 26 |
| 1 | ACETAMINOPHEN | 23 |
| 2 | METHYLPREDNISOLONE | 20 |
| 3 | RANITIDINE | 17 |
| 4 | DIPHENHYDRAMINE HYDROCHLORIDE | 14 |
| 5 | ACETAMINOPHEN 500MG | 13 |
| 6 | ACETAMINOPHEN TABLET EXTENDED RELEASE | 13 |
| 7 | LEVOTHYROXINE SODIUM | 13 |
| 8 | PAIN RELIEVER | 13 |
| 9 | ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | 11 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TETRACAINE HYDROCHLORIDE | 1 | 0.0075 |
| 1 | HUMAN ALBUMIN MICROSPHERES AND PERFLUTREN | 1 | 0.0071 |
| 2 | POTASSIUM IODIDE | 5 | 0.0034 |
| 3 | BARIUM SULFATE | 1 | 0.0023 |
| 4 | PROPARACAINE HYDROCHLORIDE | 1 | 0.0019 |
| 5 | ALEMTUZUMAB | 26 | 0.0013 |
| 6 | TEPROTUMUMAB | 7 | 0.0012 |
| 7 | MEFENAMIC ACID | 2 | 0.0009 |
| 8 | METHIMAZOLE | 6 | 0.0008 |
| 9 | STANDARDIZED SENNA CONCENTRATE AND DOCUSATE SODIUM | 1 | 0.0007 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD52-directed Cytolytic Antibody [EPC] | 26 | 0.0013 |
| 1 | Insulin-like Growth Factor-1 Receptor Inhibitor [EPC] | 7 | 0.0012 |
| 2 | Thyroid Hormone Synthesis Inhibitor [EPC] | 7 | 0.0007 |
| 3 | Provitamin D2 Compound [EPC] | 10 | 0.0003 |
| 4 | Plasma Volume Expander [EPC] | 1 | 0.0003 |
| 5 | beta Lactamase Inhibitor [EPC] | 1 | 0.0002 |
| 6 | Progestin Antagonist [EPC] | 1 | 0.0002 |
| 7 | Contrast Agent for Ultrasound Imaging [EPC] | 1 | 0.0002 |
| 8 | Cardiac Myosin Inhibitor [EPC] | 1 | 0.0002 |
| 9 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 16 | 0.0002 |